Childbirth hospitalizations produce the most surprise bills modernhealthcare.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernhealthcare.com Daily Mail and Mail on Sunday newspapers.
The U.S. new cases 7-day rolling average are 12.4 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 4.3 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 65,471
U.S. Coronavirus deaths are at 901
U.S. Coronavirus immunizations have been administered to 64.6 % of the population
The 7-day rolling average rate of growth of the pandemic shows new cases improved and deaths worsened
CDC advisers recommend resuming use of Johnson & Johnson coronavirus vaccine
New Study Shows Long Haul COVID-19 Can Kill Patients Months After Infection
email article
So far in the pandemic, support for research on drug repurposing particularly for inexpensive generics has not played a huge role in finding new treatments for COVID-19, but that appears to be changing.
Critics charge that drug repurposing is like looking for a needle in a haystack. It does not always work, and can raise false hopes and waste resources. In a March 7 interview with
60 Minutes, for instance, NIH director Francis Collins, MD, PhD, said drug repurposing is only going to work if you re kind of lucky, because you re basically picking things that were developed for a different disease.
Blood Cancer Patients, Survivors Hesitate Over COVID-19 Vaccine medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
RYE BROOK, N.Y., March 8, 2021 /PRNewswire/ A new survey of more than 6,500 U.S. blood cancer patients and survivors reveals that only half are very likely to get a COVID-19 vaccine while one in three is either unlikely or unsure about it. The nationwide survey was a collaboration between The Leukemia & Lymphoma Society (LLS), Boston University Questrom School of Business and The Behaviouralist, a London-based research consultancy.
The results come despite the serious risks facing blood cancer patients. Some early
studies suggest around half of blood cancer patients hospitalized with COVID-19 will die from the disease.